Palomino Laboratories Director Steven Denbaars Buys 12,500 Shares

What Happened
Steven Denbaars, a director of Palomino Laboratories Inc., purchased 12,500 shares on 2026-04-20 at $4.00 per share, for a total transaction value of $50,000. This was a purchase (transaction code P), which is a direct acquisition of company stock rather than a sale or option exercise.

Key Details

• Transaction date and price: 2026-04-20 at $4.00 per share.
• Shares acquired: 12,500; total value: $50,000.
• Transaction type: Purchase (open market or private purchase indicated on the Form 4).
• Shares owned after transaction: Not reported in the provided summary.
• Footnotes/plan: No 10b5-1 plan, tax withholding, or other footnotes were indicated in the provided transaction details.
• Filing timeliness: Reported with a Form 4 dated 2026-04-20 (same-day reporting per available data), so appears timely.

Context
Purchases by directors represent direct insider buying and can be of interest to investors as a signal that company insiders are acquiring shares. This single purchase is modest in dollar size ($50k) and, by itself, does not prove broader insider sentiment. No additional transactions or sales were reported in this filing.